⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for sar444245

Every month we try and update this database with for sar444245 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101)NCT04009681
Metastasis
THOR-707
Checkpoint inhi...
anti-EGFR antib...
18 Years - Synthorx, Inc, a Sanofi company
A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101)NCT04009681
Metastasis
THOR-707
Checkpoint inhi...
anti-EGFR antib...
18 Years - Synthorx, Inc, a Sanofi company
Phase 2 Study of Neoadjuvant SAR444245 Plus Cemiplimab in HPV Related Oropharynx Squamous Cell CarcinomaNCT05535023
Squamous Cell C...
Oropharynx Canc...
Head and Neck C...
SAR444245
Cemiplimab
18 Years - M.D. Anderson Cancer Center
A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101)NCT04009681
Metastasis
THOR-707
Checkpoint inhi...
anti-EGFR antib...
18 Years - Synthorx, Inc, a Sanofi company
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: